🌍·19h agoResearch
IDH1 -mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial
Publisher
N
Nature Cancer
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Nature Cancer
- Region
- Global
- Scope
- Research
- Published
- July 1, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: Nature Cancer
Scope: Research
Related coverage
More related coverage
Universitätsklinikum Heidelberg/5h ago
EU-gefördertes Forschungsprojekt zu Bauchspeicheldrüsenkrebs: Medizinische Fakultät Heidelberg nimmt Schlüsselrolle ein
UNC Chapel Hill/2h ago
Carolina’s School of Data and Information Sciences launches
UNC Chapel Hill/3h ago
Collaboration is key for Carolina’s newest school
University of Alabama at Birmingham/3h ago